Back

CCMHFpEF: Is CCM Therapy safe and effective in patients with HFpEF?

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late-Breaking Clinical Trial - Devices Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2022

About the speaker

Photo
Professor Cecilia Marianne Linde

Karolinska Institute, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail
ENDO-HF Neuromodulation in Heart Failure
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
REBALANCE-HF Roll In Cohort
Doctor M. Fudim (Durham, US)
Slides Video
Presentation thumbnail
GHIDD - Glycemic variability and hyperglycemia in HFpEF
Professor G. Fazio (Palermo, IT)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trial - Devices
Video

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources